Revolutionizing Healthcare: HealthQuad Invests in LifeSigns to Scale AI-Powered Patient Monitoring

In a significant move to revolutionize the healthcare landscape, HealthQuad, the growth venture arm of Quadria Group, has announced its investment in LifeSigns, India's leading AI-powered remote patient monitoring platform. This strategic investment underscores HealthQuad's commitment to backing innovative healthcare models that prioritize predictive care, clinical impact, and global healthcare access.

Founded by Hari Subramaniam, LifeSigns has been at the forefront of developing an integrated patient monitoring system that leverages AI to detect early signs of deterioration, enabling timely clinical decisions and ultimately saving lives. With its deployment across tier 2 cities, an occupancy-based frugal pricing model, and an easy-to-scale solution, LifeSigns is driving access to high-quality healthcare where it is most needed.

The partnership between HealthQuad and LifeSigns will focus on two key priorities: international expansion across Southeast Asia and the GCC, and strengthening LifeSigns' AI-led technology stack through selective integrations. As LifeSigns' first institutional investor, HealthQuad brings more than just capital to the table. Backed by Quadria's global healthcare ecosystem, the partnership is poised to accelerate LifeSigns' growth and expansion plans.

Rahul Agarwal, Partner at HealthQuad, emphasized the significance of this investment, stating, 'Healthcare today is built on periodic observation, while risk is real-time. The future lies in continuous monitoring led predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention, which can significantly improve outcomes and reduce healthcare costs at scale.'

Hari Subramaniam, Founder and CEO of LifeSigns, added, 'No patient should deteriorate silently because systems are not designed to continuously monitor them. That belief built LifeSigns. Our platform has demonstrated measurable clinical impact, and with HealthQuad's support, we are confident of scaling our solution to make a meaningful difference in the lives of patients globally.'

HealthQuad Fund III, a successor to HealthQuad Fund I and Fund II, aims to invest in category-defining companies that are building bold, scalable solutions to solve real-world problems. The fund's investment in LifeSigns represents a high conviction investment in the next wave of healthcare innovation, where AI delivers measurable clinical impact at scale.

The investment in LifeSigns is a testament to HealthQuad's commitment to identifying and supporting innovative healthcare startups that have the potential to transform the industry. With its global healthcare network and expertise, HealthQuad is well-positioned to help LifeSigns scale its solution and expand its reach to new markets.

As the healthcare industry continues to evolve, the importance of AI-powered remote patient monitoring cannot be overstated. With the rising demand for healthcare services, workforce constraints, and cost pressures, the ability to monitor patients continuously and act early is becoming critical. LifeSigns' innovative solution has the potential to make a significant impact in this space, and with HealthQuad's support, the company is poised for rapid growth and expansion.